Not Signed In - Phase II Study Of Lenalidomide In Patients With Metastatic Renal Cell Carcinoma
Tue, 02 Jan 2007 09:00 AM EST
... UroToday.com - The treatment of metastatic renal cell carcinoma (RCC) has undergone a dramatic evolution over the past year, with the introduction of new targeted therapies that have demonstrated improved response rates, delayed time to progression, and improved survival over traditional immunotherapeutic approaches. [click link for full article] ...
Related Topics
- Skin Cancer
- Renal Cell Cancer
- Renal cell carcinoma
- Kidney Cancer
- Metastatic Cancer
- Liver Cancer
- Small Cell Lung Cancer
- Merkel Cell Carcinoma
- Kidney (Renal Cell) Cancer
- Renal Cell (Kidney) Cancer
- Islet Cell Carcinoma
- Skin Carcinoma, Merkel Cell
- Islet Cell Carcinoma (Pancreatic)
- Islet Cell Carcinoma (Endocrine Pancreas)
- Squamous Cell Carcinoma, see Skin Cancer
- Basal Cell Carcinoma, see Skin Cancer
- Brain Cancer
- Sickle Cell Anemia
- Hepatocellular
- Renal Cell (Kidney) Cancer, Childhood
email this page
print this page
bookmark this page
feedback on this page
